Keywords: xenoport, exercises, option, co-market, solzira, usa, gsk

XenoPort exercises option to co-market Solzira in USA with GSK

Article | 16 April 2009

Print This

US drugmaker XenoPort has exercised the option contained in its deal with UK drug major GlaxoSmithKline to co-promote and share ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in